{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T16:27:29Z","timestamp":1775924849160,"version":"3.50.1"},"reference-count":29,"publisher":"Microbiology Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"abstract":"<jats:p>Smallpox (infection with Orthopoxvirus variola) remains a feared illness more than 25\u2005years after its eradication. Historically, case-fatality rates (CFRs) varied between outbreaks (&lt;1 to \u223c40\u200a%), the reasons for which are incompletely understood. The extracellular enveloped virus (EEV) form of orthopoxvirus progeny is hypothesized to disseminate infection. Investigations with the closely related Orthopoxvirus vaccinia have associated increased comet formation (EEV production) with increased mouse mortality (pathogenicity). Other vaccinia virus genetic manipulations which affect EEV production inconsistently support this association. However, antisera against vaccinia virus envelope protect mice from lethal challenge, further supporting a critical role for EEV in pathogenicity. Here, we show that the increased comet formation phenotypes of a diverse collection of variola viruses associate with strain phylogeny and geographical origin, but not with increased outbreak-related CFRs; within clades, there may be an association of plaque size with CFR. The mechanisms for variola virus pathogenicity probably involves multiple host and pathogen factors.<\/jats:p>","DOI":"10.1099\/vir.0.008169-0","type":"journal-article","created":{"date-parts":[[2009,3,10]],"date-time":"2009-03-10T18:38:47Z","timestamp":1236710327000},"page":"792-798","source":"Crossref","is-referenced-by-count":13,"title":["Smallpox virus plaque phenotypes: genetic, geographical and case fatality relationships"],"prefix":"10.1099","volume":"90","author":[{"given":"Victoria A.","family":"Olson","sequence":"first","affiliation":[{"name":"Poxvirus Team, Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mail Stop G-06, 1600 Clifton Road NE, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin L.","family":"Karem","sequence":"additional","affiliation":[{"name":"Poxvirus Team, Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mail Stop G-06, 1600 Clifton Road NE, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Smith","sequence":"additional","affiliation":[{"name":"Poxvirus Team, Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mail Stop G-06, 1600 Clifton Road NE, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Poxvirus Team, Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mail Stop G-06, 1600 Clifton Road NE, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger K.","family":"Damon","sequence":"additional","affiliation":[{"name":"Poxvirus Team, Poxvirus and Rabies Branch, Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mail Stop G-06, 1600 Clifton Road NE, Atlanta, GA 30333, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"345","reference":[{"key":"R1","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/JVI.79.10.6260-6271.2005","article-title":"Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R","volume":"79","author":"Aldaz-Carroll","year":"2005","journal-title":"J Virol"},{"key":"R2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1099\/0022-1317-13-1-9","article-title":"An antigenic difference between intracellular and extracellular rabbitpox virus","volume":"13","author":"Appleyard","year":"1971","journal-title":"J Gen Virol"},{"key":"R3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"R4","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1128\/JVI.66.7.4170-4179.1992","article-title":"Role of cell-associated enveloped vaccinia virus in cell-to-cell spread","volume":"66","author":"Blasco","year":"1992","journal-title":"J Virol"},{"key":"R5","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox","volume":"7","author":"Davies","year":"2007","journal-title":"Proteomics"},{"key":"R6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"key":"R7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"key":"R8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.1125134","article-title":"Genome sequence diversity and clues to the evolution of variola (smallpox) virus","volume":"313","author":"Esposito","year":"2006","journal-title":"Science"},{"key":"R9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.antiviral.2005.11.006","article-title":"Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R","volume":"69","author":"Gurt","year":"2006","journal-title":"Antiviral Res"},{"key":"R10","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1099\/vir.0.81260-0","article-title":"Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein","volume":"86","author":"Herrero-Mart\u00ednez","year":"2005","journal-title":"J Gen Virol"},{"key":"R11","doi-asserted-by":"crossref","first-page":"11637","DOI":"10.1128\/JVI.76.22.11637-11644.2002","article-title":"Identification of second-site mutations that enhance release and spread of vaccinia virus","volume":"76","author":"Katz","year":"2002","journal-title":"J Virol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"12266","DOI":"10.1128\/JVI.77.22.12266-12275.2003","article-title":"Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein","volume":"77","author":"Katz","year":"2003","journal-title":"J Virol"},{"key":"R13","doi-asserted-by":"crossref","first-page":"15787","DOI":"10.1073\/pnas.0609268104","article-title":"On the origin of smallpox: correlating variola phylogenics with historical smallpox records","volume":"104","author":"Li","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/JVI.70.1.272-281.1996","article-title":"Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus","volume":"70","author":"McIntosh","year":"1996","journal-title":"J Virol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/viro.1994.1542","article-title":"Vaccinia virus gene A36R encodes a M r 43\u201350 K protein on the surface of extracellular enveloped virus","volume":"204","author":"Parkinson","year":"1994","journal-title":"Virology"},{"key":"R16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1099\/0022-1317-50-1-89","article-title":"Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia","volume":"50","author":"Payne","year":"1980","journal-title":"J Gen Virol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1099\/0022-1317-66-3-643","article-title":"Extracellular release of enveloped vaccinia virus from mouse nasal epithelial cells in vivo","volume":"66","author":"Payne","year":"1985","journal-title":"J Gen Virol"},{"key":"R18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"Putz","year":"2006","journal-title":"Nat Med"},{"key":"R19","first-page":"1","article-title":"Vaccinia (smallpox","volume-title":"vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep","volume":"50","author":"Rotz","year":"2001"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1099\/0022-1317-79-6-1415","article-title":"Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell\u2013cell fusion","volume":"79","author":"Sanderson","year":"1998","journal-title":"J Gen Virol"},{"key":"R21","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1128\/MCB.6.11.3734","article-title":"Variants of vaccinia virus hemagglutinin altered in intracellular transport","volume":"6","author":"Shida","year":"1986","journal-title":"Mol Cell Biol"},{"key":"R22","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"R23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.icb.7100033","article-title":"Immunopathogenesis of poxvirus infections: forecasting the impending storm","volume":"85","author":"Stanford","year":"2007","journal-title":"Immunol Cell Biol"},{"key":"R24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid1307.061404","article-title":"Brazilian vaccinia viruses and their origins","volume":"13","author":"Trindade","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R25","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R26","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1099\/0022-1317-83-1-195","article-title":"The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface","volume":"83","author":"van Eijl","year":"2002","journal-title":"J Gen Virol"},{"key":"R27","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/JVI.67.8.4732-4741.1993","article-title":"Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination","volume":"67","author":"Wolffe","year":"1993","journal-title":"J Virol"},{"key":"R28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1172\/JCI200523220","article-title":"Antiviral chemotherapy facilitates control of poxvirus infections through inhibition of cellular signal transduction","volume":"115","author":"Yang","year":"2005","journal-title":"J Clin Invest"},{"key":"R29","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.74.24.11654-11662.2000","article-title":"Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence","volume":"74","author":"Zhang","year":"2000","journal-title":"J Virol"}],"container-title":["Journal of General Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.008169-0?crawler=true","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T15:43:58Z","timestamp":1603813438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.microbiologyresearch.org\/content\/journal\/jgv\/10.1099\/vir.0.008169-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1099\/vir.0.008169-0","relation":{},"ISSN":["0022-1317","1465-2099"],"issn-type":[{"value":"0022-1317","type":"print"},{"value":"1465-2099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}